20. November 2009 02:41
Research and Markets (http://www.researchandmarkets.com/research/410c60/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - A US and European Market Analysis" report to their offering.
[More]
695b9412-1af5-4d8a-a9fc-d0801585eab5|0|.0
Posted in: Pharmaceutical News
Tags: Antibody, Brain, Brain Cancer, Cancer, Cell, Ciprofloxacin, Follicular Lymphoma, Lung Cancer, Lymphoma, Nephrology, Neurology, Nuclear Medicine, Oncology, Radiation Therapy, Radiotherapy, Zevalin
16. November 2009 08:05
Aradigm Corporation today announced that the first patient was dosed in a 6-month, multicenter, international Phase 2 clinical trial of a novel version of inhaled ciprofloxacin (ARD-3150) in 40 adult patients with non-cystic fibrosis bronchiectasis.
[More]
16. November 2009 04:30
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
[More]
f45ef926-c5f2-4c20-8710-3e9d8d17c8b2|0|.0
Posted in: Pharmaceutical News
Tags: Antibiotic, Cancer, Cell, Ciprofloxacin, Commonwealth Fund, Diabetes, DNA, DNA Replication, E. coli, Evolution, Gene Expression, Hospital, Stress, Tetracycline, Tuberculosis
5. November 2009 07:38
Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2009 and recent highlights.
[More]
15. September 2009 02:24
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of multi-antibiotic resistant infections, today announced that it intends to enter into a Clinical Trials Agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services.
[More]
f011d7e8-1475-4955-b4bf-35af3a47faf5|0|.0
Posted in: Drug Trial News | Disease/Infection News
Tags: Allergy, Antibiotic, Biochemistry, Ciprofloxacin, Fluoroquinolone, Gonorrhea, Health and Human Services, Hospital, Penicillin, Prophylaxis, Staphylococcus aureus, Streptococcus pneumoniae
14. September 2009 07:58
Aradigm Corporation (OTCBB: ARDM) ("Aradigm") today announced it is presenting data from its Phase 1 and Phase 2a studies at the ERS Annual Congress in Vienna, Austria, September 12-16, 2009.
[More]
11. September 2009 05:49
Reportlinker.com announces that a new market research report is available in its catalogue: US and European Radiopharmaceuticals Market
[More]
728d86bc-f9d3-4654-8d1f-3d309fa76664|0|.0
Posted in: Pharmaceutical News
Tags: Antibody, Bone, Brain, Brain Cancer, Cancer, Cardiology, Cell, Ciprofloxacin, Epilepsy, Follicular Lymphoma, Hyperthyroidism, Lymphoma, Medicare, Neurology, Nuclear Medicine, Oncology, Radiation Exposure, Radiation Therapy, Radiology, Radiotherapy, Thyroid Cancer, Zevalin
4. September 2009 23:51
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.
[More]
492affa6-f40b-478f-9843-71e7c0784e11|1|5.0
Posted in: Medical Science News | Pharmaceutical News
Tags: Anthrax, Antibody, Brain, Cancer, Ciprofloxacin, Diabetes, Education, Health and Human Services, Health Disparities, Hospital, Immunology, Neuroscience, Penicillin, Vaccine
4. September 2009 01:38
At a time when many families affected by a difficult economy are struggling with the costs of prescription medications, supermarket retailer Giant Eagle, Inc. is making ten broadly used generic prescription antibiotics in 46 common dosages available for free every day at all of its 210 in-store pharmacies.
[More]
c61a6c7c-0de9-4f13-a279-674185303ca6|0|.0
Posted in: Pharmaceutical News
Tags: Acne, Amoxicillin, Ampicillin, Antibiotic, Ciprofloxacin, Conjunctivitis, Education, Erythromycin, Hospital, Penicillin, Pneumonia, Tetracycline
26. August 2009 02:01
Infection with an antimicrobial-resistant strain of typhoid fever among patients in the United States is associated with international travel, especially to the Indian subcontinent (India, Pakistan, and Bangladesh), according to a study in the August 26 issue of JAMA. The study also shows an increase in certain strains of typhoid fever that are resistant to the most commonly used medications for treatment.
[More]
11. August 2009 18:39
Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today reported financial results for the second quarter ended June 30, 2009.
[More]
6. August 2009 01:35
Aradigm Corporation (OTCBB:ARDM) has announced that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company’s inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infections associated with cystic fibrosis (“CF”).
[More]
12. April 2009 21:12
The prevalence of a certain form of drug-resistant bacteria, called multidrug-resistant gram-negative (MDRGN) organisms, far surpassed that of two other common antimicrobial-resistant infections in long-term care facilities, according to a study conducted by researchers at Hebrew SeniorLife's Institute for Aging Research.
[More]
8. February 2009 21:38
Many of the substances in our most common medicines are manufactured in India and China.
[More]
18. November 2008 21:37
Using a novel technique developed by Mitchell Sogin of the Marine Biological Laboratory (MBL) to identify different types of bacteria, scientists have completed the most precise survey to date of how microbial communities in the human gut respond to antibiotic treatment.
[More] 
Subscribe